Back to articles
Immunology7 min read

Indirect Fluorescent Antibody (IFA) Test: Principle, Procedure, and Uses

How the indirect fluorescent antibody (IFA) test uses two antibodies to detect antibodies in patient serum (and antigens in cells). Principle, procedure, syphilis example, and why the indirect design amplifies the signal.

The indirect fluorescent antibody test (IFA) is a semi-quantitative, sensitive test used to detect specific antibodies (or antigens) in a sample. It is the "indirect" arrangement of immunofluorescence: instead of one labeled antibody, it uses two, an unlabeled antibody that binds the target and a second, dye-labeled antibody that binds the first. Its most common job is finding a patient's antibodies in serum, for example when a pathogen is hard to find directly and you look instead for the immune response to it, as in the serodiagnosis of leishmaniasis, syphilis, or toxoplasmosis. The two-antibody design is what separates IFA from the direct (DFA) method, and it is also what makes IFA more sensitive. For how the two methods compare in full, see Immunofluorescence assay.

Fluorescent antibody methods - Direct and indirect immunofluorescence for the detection of antigen(Image source: Brock Biology of Microorganisms)Figure: Direct and indirect immunofluorescence for the detection of antigen (Image source: Brock Biology of Microorganisms)

IFA for the detection of Antibodies

Indirect fluorescent antibody (IFA) test can be used to detect specific antibodies against various etiological agents present in patient serum and cerebral spinal fluid (CSF) samples.

IFA is being used for the diagnosis of:

  1. Rabies
  2. Syphilis
  3. Toxoplasmosis
  4. Leishmaniasis
  5. Legionellosis

Principle

Known antigen is immobilized on a glass slide (slides smeared with cells carrying known antigens are commercially available). Test sample (patient serum) is added over the smear. If specific antibodies are present in the serum, the antigen-antibody complex is formed. The serum is washed off and a secondary antihuman immunoglobulin conjugated to a fluorochrome (fluorescein isothiocyanate or rhodamine B) is added.

On examination, the target organism or cell is visible only where the patient's antibodies have bound it and the labeled secondary antibody has attached in turn.

IFA for antibodies detection - IFA for antibodies detectionFigure: IFA for antibodies detection

Two fluorophores are commonly used: fluorescein isothiocyanate (FITC), which emits apple-green (sometimes described as yellow-green), and rhodamine, which emits red.

For example, an IFA test for the diagnosis of syphilis uses Treponema pallidum isolated from a lab animal and a smear is prepared on a glass slide. Patient serum is spread over the smear and anti-treponemal antibodies, if present, are allowed to bind. The serum is washed off and a secondary antibody labeled with fluorescein isothiocyanate (FITC) is added. On examination, the T. pallidum bacteria will only be visible. This treponemal IFA, refined with an absorption step to remove cross-reacting antibodies, is the basis of the FTA-ABS test used to confirm syphilis.

Procedure (antibody detection)

  1. A slide pre-coated with known antigen is used (commercially prepared antigen slides are available).
  2. Patient serum is applied. If specific antibody is present, it binds the fixed antigen.
  3. The slide is washed to remove unbound serum proteins.
  4. A secondary anti-human immunoglobulin antibody, labeled with FITC, is added and binds any patient antibody already attached to the antigen.
  5. The slide is washed again and examined under a fluorescence microscope. Apple-green fluorescence indicates the patient antibody is present. A titer can be estimated by testing serial serum dilutions.

IFA for detection of Antigens

Principle

Unlike the direct fluorescent antibody test, indirect detection of antigen is a two-step procedure using two antibodies: an unlabeled primary antibody that binds the antigen, and a FITC-labeled anti-species secondary antibody that binds the primary. The extra layer amplifies the signal.

  1. An unlabeled primary antibody which binds to a specific antigen, and
  2. FITC labeled anti-species secondary antibody which binds to the primary antibody-antigen complex.

Virus-infected cells or samples are fixed using acetone, methanol, or paraformaldehyde; to preserve cell morphology or tissue architecture. After incubation of the sample with the appropriate antibody (primary antibody), the excess antibody is removed by washing. A secondary antibody labeled with fluorochrome is added and incubated. Again the excess antibody is removed by washing and the smear is visualized using a fluorescence microscope.

DFA and IFA for the detection of viral antigen  - DFA and IFA for the detection of viral antigen(Image source:virology.ws)Figure: DFA and IFA for the detection of viral antigen(Image source: virology.ws)

IFA vs DFA in brief

IFA uses two antibodies and DFA uses one. The extra labeled antibody in IFA amplifies the signal, making it more sensitive than DFA, but the two incubation steps make it slower. For the full side-by-side comparison, see Immunofluorescence assay: direct vs indirect

How to Remember

Why two antibodies, and what IFA usually detects

The second antibody is a labeled megaphone. A patient's own antibody is invisible, it carries no dye. The indirect method adds a second antibody that carries the dye and clamps onto the first. Because several of these labeled "megaphones" stack on one patient antibody, the signal gets louder, which is exactly why indirect is more sensitive than direct.

Indirect leans toward antibodies in serum. When the question is "does this patient have antibodies against X" (rabies, syphilis, toxoplasmosis, leishmaniasis, legionellosis), you cannot pre-label the patient's antibody, so you relay through a labeled anti-human secondary. That relay is the indirect method's signature move.

Key exam facts in one table

Point What to remember
What it detects Antibodies in patient serum or CSF (and, in sandwich form, antigens in cells)
Antibodies used Two: unlabeled primary + labeled secondary
Secondary antibody Anti-human immunoglobulin, FITC-labeled, binds the patient's antibody
Why more sensitive than DFA Several labeled secondary antibodies stack on one primary, amplifying signal
Trade-off vs DFA Slower (two incubation steps)
Fluorophores FITC emits apple-green; rhodamine emits red
Antigen slide Known antigen is pre-fixed on the slide (commercial slides available)
Semi-quantitative Titer estimated by testing serial serum dilutions
Clinical uses Serodiagnosis of rabies, syphilis, toxoplasmosis, leishmaniasis, legionellosis
Syphilis link Treponemal IFA with an absorption step becomes the FTA-ABS test
Reading Fluorescence microscope; apple-green signal is positive
Relationship to hub Indirect method; the direct (DFA) method uses a single labeled antibody

Where students get confused

"IFA only detects antibodies." Mostly, but not only. Its classic use is finding antibodies in patient serum, but the same two-antibody logic detects antigens too (unlabeled primary against the antigen, labeled secondary against the primary). The defining feature is two antibodies, not what is being detected.

"The secondary antibody is specific to the disease." No. The secondary antibody is anti-human immunoglobulin, it binds human antibody in general, not the pathogen. That is precisely why one labeled secondary can serve many different IFA tests: the specificity comes from the patient's own antibody (or the unlabeled primary), not the label.

"IFA is better than DFA because it is more sensitive." More sensitive, yes, but not universally better. The two incubation steps make it slower, and the extra antibody adds a route for background. DFA wins when speed and clean background matter; IFA wins when sensitivity and flexibility matter.

"Apple-green and yellow-green are different dyes." They are the same dye. FITC's emission is described both ways. Rhodamine is the red one. Do not read two color words as two fluorophores.

References and further readings

  • Racaniello, V. Detecting viral proteins in infected cells or tissues by immunostaining. Virology blog.
  • Tille, P. M. (2022). Bailey & Scott's Diagnostic Microbiology (15th ed.). Elsevier.
  • Madigan, M. T., Bender, K. S., Buckley, D. H., Sattley, W. M., & Stahl, D. A. (2018). Brock Biology of Microorganisms (15th ed.). Pearson.
  • Procop, G. W., et al. (2017). Koneman's Color Atlas and Textbook of Diagnostic Microbiology (7th ed.). Wolters Kluwer.
FAQ

Frequently Asked Questions

What does the indirect fluorescent antibody (IFA) test detect?

Most often it detects specific antibodies in a patient's serum or CSF, for example antibodies against the agents of rabies, syphilis, toxoplasmosis, leishmaniasis, or legionellosis. The same two-antibody design can also detect antigens in cells.

Why does IFA use two antibodies?

A patient's own antibody carries no fluorescent label and cannot be seen. IFA adds a second, labeled antibody directed against human immunoglobulin, which binds the patient's antibody and makes it visible. Because several labeled secondary antibodies bind each primary, the signal is amplified.

Why is IFA more sensitive than DFA?

In IFA, multiple labeled secondary antibodies stack onto each primary antibody, multiplying the fluorescent signal. The direct method (DFA) uses a single labeled antibody, so its signal is not amplified.

What is the difference between IFA and FTA-ABS?

FTA-ABS is a specific application of indirect immunofluorescence used to confirm syphilis. It adds an absorption step to remove antibodies that cross-react with non-pathogenic treponemes, improving specificity.

What colors are seen in an IFA test?

FITC-labeled antibody produces apple-green (sometimes called yellow-green) fluorescence, and rhodamine-labeled antibody produces red. A positive result is the specific glow at the site where antibody has bound.

Is IFA quantitative?

It is semi-quantitative. By testing serial dilutions of the patient's serum, the laboratory can estimate an antibody titer, which is useful for judging the strength of a response or following it over time.
Acharya Tankeshwar
About Author
Acharya Tankeshwar

Tankeshwar Acharya, MSc (Medical Microbiology)

Tankeshwar Acharya is an Assistant Professor in the Department of Microbiology at Patan Academy of Health Sciences (PAHS), Nepal, where he has been teaching and practicing clinical microbiology for over 14 years. He is the founder of Microbe Online, one of the leading free microbiology education resources on the web, covering bacteriology, mycology, parasitology, immunology, and clinical laboratory diagnostics written from direct experience in both the classroom and the diagnostic laboratory.